Business Description
Redwood Pharma AB
ISIN : SE0021512134
Compare
Compare
Traded in other countries / regions
REDW.Sweden9JV0.Germany IPO Date
2021-05-04Description
Redwood Pharma AB is engaged in developing new ophthalmic pharmaceutical therapies for unmet market needs. Its development product is a new therapy to treat chronic Dry Eye Disease (DED) in post-menopausal women.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.87 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 26.7 | |||||
| 3-Year EPS without NRI Growth Rate | 27.1 | |||||
| 3-Year FCF Growth Rate | 24.7 | |||||
| 3-Year Book Growth Rate | -16.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 41.98 | |||||
| 14-Day RSI | 44.07 | |||||
| 6-1 Month Momentum % | 41.26 | |||||
| 12-1 Month Momentum % | -79.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.49 | |||||
| Quick Ratio | 1.49 | |||||
| Cash Ratio | 0.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.7 | |||||
| Shareholder Yield % | -371.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -93.21 | |||||
| ROA % | -82.62 | |||||
| ROIC % | -109.36 | |||||
| ROC (Joel Greenblatt) % | -412.89 | |||||
| ROCE % | -86.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.31 | |||||
| Price-to-Tangible-Book | 0.81 | |||||
| EV-to-EBIT | -0.23 | |||||
| EV-to-EBITDA | -0.24 | |||||
| EV-to-FCF | -0.2 | |||||
| Price-to-Net-Current-Asset-Value | 4.04 | |||||
| Earnings Yield (Greenblatt) % | -434.78 | |||||
| FCF Yield % | -364.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redwood Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.68 | ||
| Beta | 0 | ||
| Volatility % | 61.07 | ||
| 14-Day RSI | 44.07 | ||
| 14-Day ATR (€) | 0.000104 | ||
| 20-Day SMA (€) | 0.0808 | ||
| 12-1 Month Momentum % | -79.8 | ||
| 52-Week Range (€) | 0.057 - 0.42 | ||
| Shares Outstanding (Mil) | 2.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redwood Pharma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redwood Pharma AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redwood Pharma AB Frequently Asked Questions
What is Redwood Pharma AB(FRA:9JV0)'s stock price today?
The current price of FRA:9JV0 is €0.08. The 52 week high of FRA:9JV0 is €0.42 and 52 week low is €0.06.
When is next earnings date of Redwood Pharma AB(FRA:9JV0)?
The next earnings date of Redwood Pharma AB(FRA:9JV0) is 2025-02-12.
Does Redwood Pharma AB(FRA:9JV0) pay dividends? If so, how much?
Redwood Pharma AB(FRA:9JV0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers